Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2020

Apr 3, 2020

31799_dirs_2020-04-03_be496b5c-5831-492f-a2d0-ee829c249a10.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2020-04-01

Reporting Person: MICHEL GERARD J (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-01 Common Stock M 10000 $1.95 Acquired 172708 Direct
2020-04-01 Common Stock M 58519 $3.02 Acquired 231227 Direct
2020-04-01 Common Stock M 4375 $2.75 Acquired 235602 Direct
2020-04-01 Common Stock M 3090 $7.2 Acquired 238692 Direct
2020-04-01 Common Stock M 1875 $2.65 Acquired 240567 Direct
2020-04-01 Common Stock M 7673 $2.75 Acquired 248240 Direct
2020-04-01 Common Stock M 5625 $2.65 Acquired 253865 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-01 Stock Option (right to buy) $1.95 M 10000 Disposed 2026-02-09 Common Stock (10000) Direct
2020-04-01 Stock Option (right to buy) $2.75 M 4375 Disposed 2027-02-08 Common Stock (4375) Direct
2020-04-01 Stock Option (right to buy) $3.02 M 58519 Disposed 2025-01-05 Common Stock (58519) Direct
2020-04-01 Stock Option (right to buy) $7.20 M 3090 Disposed 2028-02-07 Common Stock (3090) Direct
2020-04-01 Stock Option (right to buy) $2.65 M 1875 Disposed 2027-05-22 Common Stock (1875) Direct
2020-04-01 Stock Option (right to buy) $2.75 M 7673 Disposed 2027-02-08 Common Stock (7673) Direct
2020-04-01 Stock Option (right to buy) $2.65 M 5625 Disposed 2027-05-22 Common Stock (5625) Direct

Footnotes

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted.

F3: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.

F4: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500.

F5: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F6: These options, representing the right to purchase a total of 100,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted.

F7: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company.

F8: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500.